Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
By Stephanie Ma, K. Chan, Liang Hu, T. Lee, J. Wo, I. Ng, B. Zheng, X. Guan. Gastroenterology, 2007
1,215 citations recorded by the source corpus.
Subfields: Education
View Paper: https://www.semanticscholar.org/paper/d4f8c5cd6def5bd78f12f43ede8836a8d68a6b0c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- S. Tu
- S. Takaishi
- S. Ma
- T. Okumura
- Sophie S. W. Wang
- Tk Lee
- W. Shibata
- Kw Chan
Citations in the corpus
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 (2009, methodology): “Based on previous published reports regarding CSCs in solid tumors [7–21], the following markers were studied: CD24, CD44, CD133, and CD166.”
- CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway (2008, methodology): “A total of 5 104 CD133þ cells isolated from Huh7 human HCC cell line were injected subcutaneously into nude mice, as previously described (Ma et al., 2007).”
- MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. (2012, neutral): “Similarly, the expression of various selected oncofetal genes, namely Afp , Igf2 , and Src , together with the cancer stem cell marker genes Prom1 , Thy1 , and Epcam , could be first detected in the livers of young Mir122a –/– mice, and this was followed by further increases in the expression of the”